(MENAFN- Newsfile Corp) Grabar Law Office Investigates Claims on Behalf of Shareholders of Natera, Inc. (NTRA)
Philadelphia, Pennsylvania--(Newsfile Corp. - August 12, 2023) - Grabar Law Office is investigating potential claims on behalf of Natera, Inc. (NASDAQ: NTRA) shareholders. The investigation concerns whether certain officers of Natera have breached their fiduciary duties owed to the company.
A federal securities fraud complaint alleges that Natera, through certain of its officers, misrepresented and/or failed to disclose that: (1) Panorama was not reliable and resulted in high rates of false positives; (2) Prospera did not have superior precision compared to competing tests; (3) as a result of Defendants' false and misleading claims about Natera's technology, the company was exposed to substantial legal and regulatory risks; (4) Natera relied upon deceptive sales and billing practices to drive its revenue growth; and (5) as a result of the foregoing, Defendants' statements about the company's business, operations, and prospects lacked a reasonable basis.
Current Natera shareholders who have held Natera stock since before February 26, 2020, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them.
If you would like to learn more about this matter, you are encouraged to visit , contact us at , or call Joshua Grabar at 267-507-6085.
attorney advertising disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email:
To view the source version of this press release, please visit
MENAFN12082023004218003983ID1106844160
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.